Gregg Honigblum, co-founder and Chief Revenue Officer. Gregg Honigblum has over 30 years of experience as a financier for emerging growth companies specializing in the healthcare sector. From 2001-2013, he was the CEO and co-founder of Creation Capital LLC and Creation Capital Advisors, an investment banking firm and Broker Dealer with offices in New York City and Austin, TX. Gregg Honigblum provided strategic advisory services and raised over $500 million in private equity for numerous businesses in the healthcare space. He has been instrumental in providing early stage capital for Myriad Genetics, Inc(symbol MYGN), and Acacia Biosciences which merged with Rosetta Inpharmatics, Inc. and is now a wholly owned subsidiary of Merck. From 2014 to 2016, he was a Managing Director at Westlake Securities in Austin, TX leading their healthcare banking practice. Mr. Honigblum holds a BA in Economics from the University of Texas at Austin.
George Fencl brings significant experience in the healthcare space, whether preparing early-phase brands for successful launch, carving out emerging therapeutic classes, strengthening market position of follower products, or re-establishing competitive strength and leadership of well-established offerings and companies. As a strategic account planner for Young and Rubicam, in New York, he has lead major marketing initiatives for Bristol-Myers, Microsoft, LasikPlus, United Healthcare, Abbott/AbbVie, Dell, AARP, J&J and many others. At leading SF-based healthcare agency, Giant Creative, George Fencl established digital strategies and deployed successful promotions for some of the highest selling pharmaceutical products in the most recent decade, both blockbusters and new category killers. George Fencl holds a BA from Harvard University.